Skip to main content
SupplementScience

Myo-Inositol — Frequently Asked Questions

This content is for informational purposes only and does not constitute medical advice. Consult your healthcare provider before starting any supplement. Full disclaimer

Frequently Asked Questions

How long does myo-inositol take to work for PCOS?

Most clinical trials show improvements in insulin sensitivity and androgen levels within 3-6 months. Ovulation restoration may occur as early as 8-14 weeks. Menstrual cycle regulation often improves within 2-3 cycles. For IVF preparation, most protocols recommend starting myo-inositol at least 3 months before the stimulation cycle. Consistency is key — daily dosing must be maintained for the full benefit.

Should I take myo-inositol or D-chiro-inositol for PCOS?

The 2017 international consensus recommends a 40:1 ratio of myo-inositol to D-chiro-inositol, reflecting the physiological plasma ratio. Myo-inositol alone at 4g daily is also well-supported. High doses of D-chiro-inositol alone may actually worsen oocyte quality — a paradox explained by its role in increasing androgen production in the ovary when present in excess. The safest approach is either myo-inositol alone or the 40:1 combination.

Is myo-inositol as effective as metformin for PCOS?

Several head-to-head trials have shown comparable efficacy between myo-inositol (4g daily) and metformin (1500mg daily) for improving insulin resistance and restoring ovulation in PCOS. Myo-inositol consistently shows fewer GI side effects than metformin, making it better tolerated. Some researchers advocate for combination therapy in severe insulin resistance. Myo-inositol is now considered a first-line supplement option alongside or as an alternative to metformin for PCOS management.

Full Myo-Inositol Guide

References

  1. (). Effects of myo-inositol in women with PCOS: a systematic review of randomized controlled trials. Gynecological Endocrinology. DOI
  2. (). Results from the International Consensus Conference on Myo-inositol and D-chiro-inositol in Obstetrics and Gynecology. Gynecological Endocrinology. DOI
  3. (). Randomized, double blind placebo-controlled trial: effects of myo-inositol on ovarian function and metabolic factors in women with PCOS. European Review for Medical and Pharmacological Sciences.